Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valent

Showing results (281-290 of 316) with videos related to

Pageof 32
Sort By:
Blood|September 25, 2001
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemiaW R Sperr, J H Jordan, M Baghestanian, et al.
Leukemia Research|August 4, 2018
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)J Kaivers, M Lauseker, B Hildebrandt, et al.
Leukemia|September 30, 2005
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)U Germing, B Hildebrandt, M Pfeilstöcker, et al.
Leukemia|October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosisM Jawhar, J Schwaab, S Schnittger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2001
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1S Vrtala, K Hirtenlehner, M Susani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activationP Valent, C Akin, K Hartmann, et al.
Leukemia|November 6, 2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cellsU Rix, L L Remsing Rix, A S Terker, et al.
Leukemia|January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disordersP Valent, K Sotlar, K Blatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2004
Vaccination with genetically engineered allergens prevents progression of allergic diseaseV Niederberger, F Horak, S Vrtala, et al.
Allergy|October 31, 2017
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot studyJ Eckl-Dorna, R Fröschl, C Lupinek, et al.
Pageof 32

Showing results (281-290 of 316) with videos related to

Sort By:
Pageof 32
Blood|September 25, 2001
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemiaW R Sperr, J H Jordan, M Baghestanian, et al.
Leukemia Research|August 4, 2018
The IPSS-R has prognostic impact in untreated patients with MDS del(5q)J Kaivers, M Lauseker, B Hildebrandt, et al.
Leukemia|September 30, 2005
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)U Germing, B Hildebrandt, M Pfeilstöcker, et al.
Leukemia|October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosisM Jawhar, J Schwaab, S Schnittger, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2001
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1S Vrtala, K Hirtenlehner, M Susani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activationP Valent, C Akin, K Hartmann, et al.
Leukemia|November 6, 2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cellsU Rix, L L Remsing Rix, A S Terker, et al.
Leukemia|January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disordersP Valent, K Sotlar, K Blatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2004
Vaccination with genetically engineered allergens prevents progression of allergic diseaseV Niederberger, F Horak, S Vrtala, et al.
Allergy|October 31, 2017
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot studyJ Eckl-Dorna, R Fröschl, C Lupinek, et al.
Pageof 32